Bausch & Lomb Corp(BLCO)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,549 of 2,960 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
BLCO Stock Analysis & AI Quality Score
Data updated 2026-09-12AI stock analysis and institutional research for Bausch & Lomb Corp (BLCO), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BLCO at 51.2/100 on a 32-signal composite quality model, placing it at rank #1,549 of 2,960 stocks — the bottom half of the AI-ranked universe. BLCO scores in the top quartile across earnings quality (88.2), revenue scale (78.7). Areas of concern include institutional flow (25.0) and balance sheet strength (30.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 33.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Bausch & Lomb Corp reports quarterly revenue of $1.4B, net income of $-14.0M, an operating margin of 5.9%. Top institutional holders of BLCO by reported 13-F value include ICAHN CARL C, OAKTREE CAPITAL MANAGEMENT, DEUTSCHE BANK AG\, based on the most recent SEC filings. BLCO trades on the NYSE exchange and files with the SEC under CIK 1860742. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BLCO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bausch & Lomb Corp directly from SEC EDGAR. Bausch & Lomb Corp's 13F Pro composite quality score has ranged between 42 and 52 since 2026, currently 51.2 — an improving long-term trajectory across 49 quarterly and live scoring snapshots.
Revenue
Q2 2026
$1.4B
Net Income
Q2 2026
$-14.0M
Free Cash Flow
Q2 2026
$82.0M
Operating Margin
Q2 2026
5.9%
ROIC
Q2 2026
2.9%
D/E Ratio
Q2 2026
0.80
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+6.5% YoYNet Income
-13.6% YoYOperating Income
-30.2% YoYEPS (Diluted)
-13.3% YoYTotal Assets
+4.1% YoYTotal Debt
+5.2% YoYOp. Cash Flow
+22.0% YoYFree Cash Flow
-11.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.10B +6.5% | $4.79B +15.6% | $4.15B +10.0% | $3.77B +0.1% | $3.77B +10.3% | $3.41B |
| Net Income | $-360.0M -13.6% | $-317.0M -21.9% | $-260.0M -4433.3% | $6.0M -96.7% | $182.0M +1111.1% | $-18.0M |
| Operating Income | $113.0M -30.2% | $162.0M +24.6% | $130.0M -37.2% | $207.0M -37.1% | $329.0M +26.5% | $260.0M |
| EPS (Diluted) | $-1.02 -13.3% | $-0.90 -21.6% | $-0.74 -3800.0% | $0.02 -96.2% | $0.52 +1140.0% | $-0.05 |
| Total Assets | $14.02B +4.1% | $13.47B +0.2% | $13.44B +20.6% | $11.14B +3.0% | $10.82B | — |
| Total Debt | $5.08B +5.2% | $4.82B +5.1% | $4.59B +86.6% | $2.46B | $0.00 | — |
| Operating Cash Flow | $283.0M +22.0% | $232.0M +1464.7% | $-17.0M -104.9% | $345.0M -60.5% | $873.0M +67.2% | $522.0M |
| Free Cash Flow | $-66.0M -11.9% | $-59.0M +70.2% | $-198.0M -216.5% | $170.0M -75.0% | $680.0M +152.8% | $269.0M |
Get alerted when BLCO's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Bausch & Lomb Corp including:
Top Institutional Holders of BLCO
ICAHN CARL C
$58.0M3,500,000 shOAKTREE CAPITAL MANAGEMENT LP
$57.0M3,441,042 shDEUTSCHE BANK AG\
$56.7M3,423,046 shD. E. Shaw & Co., Inc.
$55.0M3,323,021 shDAVIDSON KEMPNER CAPITAL MANAGEMENT LP
$52.3M3,158,972 shGOLDENTREE ASSET MANAGEMENT LP
$44.0M2,660,508 shPRICE T ROWE ASSOCIATES INC /MD/
$35.8M2,161,232 shCASPIAN CAPITAL LP
$33.1M1,999,043 shGLENVIEW CAPITAL MANAGEMENT, LLC
$31.8M1,918,148 shARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$22.6M1,364,980 sh
| Fund | Value | Shares |
|---|---|---|
| ICAHN CARL C | $58.0M | 3,500,000 |
| OAKTREE CAPITAL MANAGEMENT LP | $57.0M | 3,441,042 |
| DEUTSCHE BANK AG\ | $56.7M | 3,423,046 |
| D. E. Shaw & Co., Inc. | $55.0M | 3,323,021 |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | $52.3M | 3,158,972 |
| GOLDENTREE ASSET MANAGEMENT LP | $44.0M | 2,660,508 |
| PRICE T ROWE ASSOCIATES INC /MD/ | $35.8M | 2,161,232 |
| CASPIAN CAPITAL LP | $33.1M | 1,999,043 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $31.8M | 1,918,148 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $22.6M | 1,364,980 |
Companies Similar to BLCO
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Bausch Health Companies Inc.
Envista Holdings Corp
Elanco Animal Health Inc
INTEGRA LIFESCIENCES HOLDINGS CORP
Fortrea Holdings Inc.
Enovis CORP
National Vision Holdings, Inc.
TRUPANION, INC.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put BLCO on your watchlist
Track score changes the day Bausch & Lomb Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is BLCO a good stock to buy?
13F Pro's AI-powered analysis of Bausch & Lomb Corp (BLCO) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BLCO are available on the BLCO stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. BLCO is classified as a mid company.
Which hedge funds own BLCO?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BLCO. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Bausch & Lomb Corp's investment landscape.